Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACEI and ARB in Primary Hyperoxaluria
NCT00280215Phase 3Withdrawn
- Sponsor
- Mayo Clinic
- Start
- Dec 2007
- Primary completion
- Dec 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of lisinopril, losartan in Primary hyperoxaluria (PH), sponsored by Mayo Clinic. Planned start Dec 2007; status: withdrawn.
02
Drugs
lisinoprillosartan
03
Conditions
Primary hyperoxaluria (PH)
Beyond the preview
Go deeper on NCT00280215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280215.